• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Anorexiants Market Growth, Trends, Size, Share, Top Growing Companies | Pfizer Inc. (U.S.), GlaxoSmithKline Plc (U.K.), Novartis AG and More

Share:

October 11, 2022

“Global Anorexiants market” the new research report adds to Data Bridge Market Research’s reports database. This Research Report is spread across 350 Page, 220 No of Tables, And 60 No Figures summarizing Top companies, with tables and figures. Anorexiants market analysis document is created by thoroughly understanding the business environment which best suits the requirements of the client. With Anorexiants market research document, it becomes easy to develop a successful marketing strategy for the business. This industry report is a complete overview of the market that takes into account various aspects of product definition, market segmentation based on various parameters, and the established merchant landscape. Estimations about the rise or fall of the CAGR value for a specific forecast period are also mentioned in the report. The winning Anorexiants market report not only gives the advantage to develop the business but also helps to outshine the competition.

Data Bridge Market Research analyses that the anorexiants market was valued at USD 0.82 billion in 2021 and is expected to reach USD 1.22 billion by 2029, registering a CAGR of 5.12% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Anorexiants, often known as appetite suppressants, are a type of medication used to treat obesity. This medicine reduces food consumption by acting on the brain to inhibit appetite. Obesity is a long-term condition in which an individual’s extra body fat builds up to the point where it threatens his or her health. When people consume more calories than they expend over time, this occurs. Anorexiants are CNS stimulants that reduce appetite and are available as immediate and extended-release tablets. These are prescription medications that should be used in conjunction with a low-calorie diet and regular exercise.

Read more here

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Digital Journal

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Primary Myelofibrosis Pipeline Landscape Analysis, 2020 Featuring Novartis, Geron Corporation, NS Pharma, Actuate Therapeutics, Suzhou Zelgen Biopharmaceuticals, CTI BioPharma, Covance, and More – ResearchAndMarkets.com
  • AI-Enabled Pathology Company PathAI Scores $165MAI-Enabled Pathology Company PathAI Scores $165M
  • Femtech Markets Look Beyond Fertility, According to New ReportFemtech Markets Look Beyond Fertility, According to New Report
  • DarioHealth Acquires Digital Behavioral Health Platform WayForwardDarioHealth Acquires Digital Behavioral Health Platform WayForward
  • Backed by Khosla Ventures, Rubedo Life Sciences Secures $12M for Drug Discovery PlatformBacked by Khosla Ventures, Rubedo Life Sciences Secures $12M for Drug Discovery Platform
  • Former Hospital CIO Finds 177% Increase as Hackers Breached 21.3M Healthcare Records in 2H of 2020Former Hospital CIO Finds 177% Increase as Hackers Breached 21.3M Healthcare Records in 2H of 2020
  • LIVTENCITY (maribavir) Receives Positive CADTH Recommendation for Adults with Post-Transplant Cytomegalovirus (CMV) InfectionLIVTENCITY (maribavir) Receives Positive CADTH Recommendation for Adults with Post-Transplant Cytomegalovirus (CMV) Infection
  • Health Carousel Announces Acquisition Of LucidityHealth Carousel Announces Acquisition Of Lucidity

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications